News

8.19.2014

Revolutionary Radiation Therapy System Coming to Sylvester

First MRI-Guided Radiation Therapy System Installed on the East Coast

Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine is making a new state-of-the-art weapon available to its patients, becoming only the fourth facility in the U.S. and the first on the east coast to acquire an MRI-guided radiation therapy system from ViewRay Inc. The MRIdian (me-rid-i-an) system is the first and only FDA cleared system of its kind and provides a unique combination of simultaneous radiation therapy delivery and continuous magnetic resonance imaging (MRI) for the treatment of cancer.

Because MRI technology eliminates the radiation exposure associated with computed tomography (CT) scans, the MRIdian system allows for continuous imaging during the delivery of radiation therapy. Physicians are able to directly view and track the tumor during treatment. The system also permits the physician to adapt treatment based on changes in the tumor and surrounding tissues.

For the first time, doctors are able to see the tumor they are treating continuously, enabling personalized and truly adaptive radiotherapy. The MRIdian system offers this advancement to the full spectrum of patients who are treated with radiation and establishes a new level of patient care.

“At Sylvester, we have a long-standing emphasis on the integration of advanced imaging techniques in our clinical practice and research, and the MRIdian system is a natural extension into treatment delivery,” said Alan Pollack, M.D., Ph.D., professor and Chair of Radiation Oncology at the University of Miami Miller School of Medicine. “Real-time monitoring of tumor and normal tissues using MRI-guided radiotherapy is a new paradigm that will translate into significant gains in tumor control and reduced toxicity.”

“Under the leadership of Dr. Pollack, Sylvester radiation-oncologists continue to push the envelope in bringing the most precise and effective therapies to our patients,” said Stephen D. Nimer, M.D., Director of Sylvester Comprehensive Cancer Center. “Putting the MRIdian into the hands of our experts is a benefit for all cancer patients in South Florida.”

Since its first clinical use in January of this year, the MRIdian system has demonstrated success in treating a wide array of patients. The ViewRay system is expected to be installed at Sylvester by early 2015.

News Archives

Office of the Dean

A message from the dean

Med

Read Med

e-Update

Read e-Update